Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome
Uptake of ASA/NSAIDs chemoprevention is modest among individuals with LS. Patient perceptions of the pros and cons of ASA, more so than demographic and disease-related factors, were associated with chemoprevention uptake.
Authors
- Sachi Singhal (ORCID: https://orcid.org/0000-0003-0114-8130)
- Emma D. Riggs
- Michael J. Hall (ORCID: https://orcid.org/0000-0003-4515-3409)
- Yana Chertock (ORCID: https://orcid.org/0000-0002-3508-9143)
- Mary B. Daly (ORCID: https://orcid.org/0000-0002-7490-6038)
- Karen Ruth
- Juan Pablo Chavez-Salas
Institutions
- Fox Chase Cancer Center (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1200/po-24-00562
- Citations
- 5
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- National Cancer Institute